Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists-Reference-Cited by-同舟云学术

Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists

Published:2000-08-26 Issue:19 Volume:43 Page:3549-3557
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

van Vliet L. Alexander,Rodenhuis Nienke,Wikström Håkan,Pugsley Thomas A.,Serpa Kevin A.,Meltzer Leonard T.,Heffner Thomas G.,Wise Lawrence D.,Lajiness Mary E.,Huff Rita M.,Svensson Kjell,Haenen Guido R. M. M.,Bast Aalt

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000087z

Reference31 articles.

1. Reactive Oxygen Species and the Central Nervous System

2. Peripheral markers of oxidative stress in Parkinson’s disease. the role of L-DOPA

3. The role of dopamine agonists in early Parkinson's disease

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rh-Catalyzed Sequential Asymmetric Hydrogenations of 3-Amino-4-Chromones Via an Unusual Dynamic Kinetic Resolution Process;Journal of the American Chemical Society;2022-10-18

2. Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification;European Journal of Medicinal Chemistry;2022-07

3. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease;Biomolecules;2022-02-01

4. 2-aminothiazoles in drug discovery: Privileged structures or toxicophores?;Chemico-Biological Interactions;2020-10

5. Paeonol Derivatives and Pharmacological Activities: A Review of Recent Progress;Mini-Reviews in Medicinal Chemistry;2020-05-11